Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 34 |
NetGPI | no | yes: 0, no: 34 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 17 |
GO:0110165 | cellular anatomical entity | 1 | 17 |
Related structures:
AlphaFold database: A4HAZ7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 126 | 128 | PF00675 | 0.337 |
CLV_NRD_NRD_1 | 273 | 275 | PF00675 | 0.620 |
CLV_NRD_NRD_1 | 384 | 386 | PF00675 | 0.527 |
CLV_NRD_NRD_1 | 426 | 428 | PF00675 | 0.509 |
CLV_NRD_NRD_1 | 458 | 460 | PF00675 | 0.666 |
CLV_PCSK_FUR_1 | 456 | 460 | PF00082 | 0.543 |
CLV_PCSK_KEX2_1 | 126 | 128 | PF00082 | 0.329 |
CLV_PCSK_KEX2_1 | 273 | 275 | PF00082 | 0.620 |
CLV_PCSK_KEX2_1 | 384 | 386 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 426 | 428 | PF00082 | 0.509 |
CLV_PCSK_KEX2_1 | 458 | 460 | PF00082 | 0.669 |
CLV_PCSK_SKI1_1 | 182 | 186 | PF00082 | 0.396 |
CLV_PCSK_SKI1_1 | 239 | 243 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 273 | 277 | PF00082 | 0.631 |
CLV_PCSK_SKI1_1 | 4 | 8 | PF00082 | 0.400 |
DEG_APCC_DBOX_1 | 145 | 153 | PF00400 | 0.667 |
DEG_APCC_DBOX_1 | 272 | 280 | PF00400 | 0.452 |
DEG_APCC_DBOX_1 | 406 | 414 | PF00400 | 0.265 |
DOC_CYCLIN_RxL_1 | 177 | 187 | PF00134 | 0.620 |
DOC_CYCLIN_yCln2_LP_2 | 241 | 247 | PF00134 | 0.309 |
DOC_MAPK_DCC_7 | 307 | 315 | PF00069 | 0.365 |
DOC_MAPK_DCC_7 | 426 | 434 | PF00069 | 0.307 |
DOC_MAPK_gen_1 | 140 | 149 | PF00069 | 0.569 |
DOC_MAPK_gen_1 | 307 | 315 | PF00069 | 0.356 |
DOC_MAPK_gen_1 | 351 | 361 | PF00069 | 0.335 |
DOC_MAPK_gen_1 | 372 | 382 | PF00069 | 0.306 |
DOC_MAPK_gen_1 | 426 | 434 | PF00069 | 0.307 |
DOC_MAPK_HePTP_8 | 305 | 317 | PF00069 | 0.244 |
DOC_MAPK_MEF2A_6 | 230 | 238 | PF00069 | 0.403 |
DOC_MAPK_MEF2A_6 | 307 | 315 | PF00069 | 0.317 |
DOC_MAPK_MEF2A_6 | 354 | 362 | PF00069 | 0.361 |
DOC_PP4_FxxP_1 | 289 | 292 | PF00568 | 0.267 |
DOC_PP4_FxxP_1 | 40 | 43 | PF00568 | 0.665 |
DOC_USP7_MATH_1 | 65 | 69 | PF00917 | 0.640 |
DOC_USP7_MATH_2 | 394 | 400 | PF00917 | 0.290 |
DOC_WW_Pin1_4 | 354 | 359 | PF00397 | 0.302 |
DOC_WW_Pin1_4 | 39 | 44 | PF00397 | 0.586 |
LIG_14-3-3_CanoR_1 | 195 | 199 | PF00244 | 0.620 |
LIG_14-3-3_CanoR_1 | 239 | 244 | PF00244 | 0.461 |
LIG_Actin_WH2_2 | 310 | 327 | PF00022 | 0.374 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.518 |
LIG_CtBP_PxDLS_1 | 431 | 435 | PF00389 | 0.360 |
LIG_FHA_1 | 119 | 125 | PF00498 | 0.544 |
LIG_FHA_1 | 240 | 246 | PF00498 | 0.341 |
LIG_FHA_1 | 29 | 35 | PF00498 | 0.510 |
LIG_FHA_1 | 355 | 361 | PF00498 | 0.302 |
LIG_FHA_1 | 393 | 399 | PF00498 | 0.428 |
LIG_FHA_1 | 76 | 82 | PF00498 | 0.576 |
LIG_LIR_Apic_2 | 145 | 151 | PF02991 | 0.464 |
LIG_LIR_Nem_3 | 111 | 115 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 199 | 204 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.539 |
LIG_Pex14_2 | 216 | 220 | PF04695 | 0.310 |
LIG_REV1ctd_RIR_1 | 4 | 13 | PF16727 | 0.553 |
LIG_SH2_CRK | 201 | 205 | PF00017 | 0.287 |
LIG_SH2_CRK | 79 | 83 | PF00017 | 0.544 |
LIG_SH2_SRC | 52 | 55 | PF00017 | 0.483 |
LIG_SH2_STAP1 | 32 | 36 | PF00017 | 0.530 |
LIG_SH2_STAT3 | 225 | 228 | PF00017 | 0.374 |
LIG_SH2_STAT5 | 148 | 151 | PF00017 | 0.600 |
LIG_SH2_STAT5 | 196 | 199 | PF00017 | 0.510 |
LIG_SH2_STAT5 | 52 | 55 | PF00017 | 0.565 |
LIG_SH3_3 | 281 | 287 | PF00018 | 0.403 |
LIG_SUMO_SIM_anti_2 | 208 | 213 | PF11976 | 0.229 |
LIG_SUMO_SIM_anti_2 | 356 | 363 | PF11976 | 0.306 |
LIG_SUMO_SIM_anti_2 | 437 | 442 | PF11976 | 0.498 |
LIG_SUMO_SIM_par_1 | 42 | 49 | PF11976 | 0.578 |
LIG_SUMO_SIM_par_1 | 95 | 101 | PF11976 | 0.583 |
LIG_SxIP_EBH_1 | 152 | 164 | PF03271 | 0.456 |
LIG_TRAF2_1 | 128 | 131 | PF00917 | 0.487 |
LIG_TRAF2_1 | 417 | 420 | PF00917 | 0.293 |
LIG_TYR_ITSM | 197 | 204 | PF00017 | 0.375 |
MOD_CK1_1 | 399 | 405 | PF00069 | 0.546 |
MOD_CK2_1 | 105 | 111 | PF00069 | 0.555 |
MOD_CK2_1 | 414 | 420 | PF00069 | 0.350 |
MOD_GlcNHglycan | 107 | 110 | PF01048 | 0.553 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.307 |
MOD_GlcNHglycan | 205 | 208 | PF01048 | 0.300 |
MOD_GlcNHglycan | 248 | 252 | PF01048 | 0.637 |
MOD_GlcNHglycan | 268 | 272 | PF01048 | 0.557 |
MOD_GlcNHglycan | 302 | 305 | PF01048 | 0.479 |
MOD_GlcNHglycan | 401 | 404 | PF01048 | 0.527 |
MOD_GlcNHglycan | 8 | 12 | PF01048 | 0.511 |
MOD_GSK3_1 | 199 | 206 | PF00069 | 0.293 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.481 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.459 |
MOD_GSK3_1 | 392 | 399 | PF00069 | 0.367 |
MOD_GSK3_1 | 430 | 437 | PF00069 | 0.385 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.581 |
MOD_N-GLC_1 | 220 | 225 | PF02516 | 0.352 |
MOD_N-GLC_1 | 75 | 80 | PF02516 | 0.468 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.539 |
MOD_NEK2_1 | 234 | 239 | PF00069 | 0.425 |
MOD_NEK2_1 | 247 | 252 | PF00069 | 0.605 |
MOD_NEK2_1 | 422 | 427 | PF00069 | 0.455 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.436 |
MOD_PIKK_1 | 224 | 230 | PF00454 | 0.441 |
MOD_PIKK_1 | 239 | 245 | PF00454 | 0.350 |
MOD_PKA_2 | 194 | 200 | PF00069 | 0.453 |
MOD_PKA_2 | 317 | 323 | PF00069 | 0.404 |
MOD_PKA_2 | 457 | 463 | PF00069 | 0.582 |
MOD_PKB_1 | 265 | 273 | PF00069 | 0.351 |
MOD_PKB_1 | 363 | 371 | PF00069 | 0.445 |
MOD_Plk_1 | 220 | 226 | PF00069 | 0.296 |
MOD_Plk_1 | 247 | 253 | PF00069 | 0.511 |
MOD_Plk_1 | 267 | 273 | PF00069 | 0.499 |
MOD_Plk_1 | 320 | 326 | PF00069 | 0.524 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.383 |
MOD_Plk_4 | 65 | 71 | PF00069 | 0.432 |
MOD_ProDKin_1 | 354 | 360 | PF00069 | 0.347 |
MOD_ProDKin_1 | 39 | 45 | PF00069 | 0.454 |
TRG_DiLeu_BaEn_1 | 356 | 361 | PF01217 | 0.396 |
TRG_DiLeu_BaLyEn_6 | 355 | 360 | PF01217 | 0.361 |
TRG_ENDOCYTIC_2 | 112 | 115 | PF00928 | 0.405 |
TRG_ENDOCYTIC_2 | 201 | 204 | PF00928 | 0.311 |
TRG_ENDOCYTIC_2 | 374 | 377 | PF00928 | 0.458 |
TRG_ENDOCYTIC_2 | 79 | 82 | PF00928 | 0.503 |
TRG_ER_diArg_1 | 272 | 274 | PF00400 | 0.529 |
TRG_ER_diArg_1 | 362 | 365 | PF00400 | 0.540 |
TRG_ER_diArg_1 | 384 | 386 | PF00400 | 0.364 |
TRG_ER_diArg_1 | 455 | 458 | PF00400 | 0.639 |
TRG_ER_diArg_1 | 461 | 464 | PF00400 | 0.680 |
TRG_NES_CRM1_1 | 322 | 334 | PF08389 | 0.446 |
TRG_Pf-PMV_PEXEL_1 | 182 | 187 | PF00026 | 0.469 |
TRG_Pf-PMV_PEXEL_1 | 239 | 243 | PF00026 | 0.449 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAN2 | Leptomonas seymouri | 42% | 71% |
A0A0N1PB02 | Leptomonas seymouri | 65% | 71% |
A0A0S4J6C6 | Bodo saltans | 41% | 72% |
A0A1X0P9A6 | Trypanosomatidae | 50% | 68% |
A0A3R7K2Y9 | Trypanosoma rangeli | 49% | 68% |
A0A3S5H668 | Leishmania donovani | 45% | 92% |
A0A3S5H669 | Leishmania donovani | 44% | 73% |
A0A3S7X835 | Leishmania donovani | 66% | 83% |
A4H5C9 | Leishmania braziliensis | 46% | 100% |
A4H5D0 | Leishmania braziliensis | 45% | 100% |
A4HAZ9 | Leishmania braziliensis | 93% | 75% |
A4HB01 | Leishmania braziliensis | 94% | 80% |
A4HTM0 | Leishmania infantum | 45% | 92% |
A4HTM1 | Leishmania infantum | 44% | 73% |
A4HTM2 | Leishmania infantum | 40% | 100% |
A4IA57 | Leishmania infantum | 66% | 83% |
C6K3V8 | Leptomonas seymouri | 44% | 77% |
C6K3V9 | Leptomonas seymouri | 41% | 71% |
C9ZMY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 49% | 69% |
E8NHE5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 39% | 74% |
E8NHF8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 37% | 77% |
E9AME6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 45% | 92% |
E9AME7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 43% | 73% |
E9AMF6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 42% | 100% |
E9B571 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 85% |
Q4Q1U8 | Leishmania major | 41% | 100% |
Q4Q2R4 | Leishmania major | 66% | 100% |
Q4Q310 | Leishmania major | 41% | 70% |
Q4Q312 | Leishmania major | 40% | 70% |
Q4Q340 | Leishmania major | 41% | 70% |
Q4Q342 | Leishmania major | 41% | 70% |
Q4QI90 | Leishmania major | 42% | 100% |
Q4QI91 | Leishmania major | 45% | 100% |